Approved, with the licence restricted or suspended.
Multi-Jurisdiction Regulatory Status
Official licensing, rolling submissions, or authorization status tracked across major health authorities.
| Regulatory Authority | Status & Details |
|---|---|
| US FDA | Approved Restricted Or Suspended Date: 2023-11-09FDA approval / licensure action (public FDA materials) |
| EMA (Europe) | Not Filed / Pre-submission |
| Health Canada | Not Filed / Pre-submission |
| TGA (Australia) | Not Filed / Pre-submission |
Progress and adoption outlook
Where this candidate sits on a fixed development ladder, and when a licence and a routine-use recommendation could follow in each jurisdiction, as scenario bands. Input grade: Regulator-confirmed status date in at least one jurisdiction.
- Preclinical
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Submitted to a regulator
- Under regulatory review
- Approved / authorised
- Recommended for routine use
Stopped at unknown stage
Approved, restricted or suspended. No adoption window is projected for a stopped programme.
Scientific Profile & Documentation
- Platform Architecture
- See FDA product page / label
- Lead Developer
- Valneva Austria GmbH
- Next Expected Milestone
- US-licensed — see product label / ACIP for use; further supplements may expand indication
- Analyst & Development Notes
- FDA CBER licensed / approved vaccine (regulator-confirmed US listing). First chikungunya vaccine licensed in US; later subject to post-approval safety actions — verify current FDA status. May also have later supplements (strain updates, age expansions); see product page. Check live FDA communications for current license status (post-approval actions possible).
- Primary Source Documentation
- FDA — IXCHIQ →
Registered Clinical Trials & Studies
Direct registry links to active, completed, or pivotal registration studies across phases.
No primary ClinicalTrials.gov record linked directly. Study data tracked via regulatory submission filings and peer-reviewed releases.
Milestone Overview
-
Stage VerificationApproved Restricted Or Suspended confirmed as of 2026-10-31.
-
Target MilestoneUS-licensed — see product label / ACIP for use; further supplements may expand indication
Vaccine Data Navigator Candidate Profile Registry:
This candidate profile is indexed across all clinical development levels (Preclinical through Phase 1–3, Regulatory Filing, and Licensure) from primary registry databases (ClinicalTrials.gov, WHO ICTRP, FDA CBER, EMA, Health Canada, TGA Australia). Data are updated continuously to track global biologic and vaccine pipelines.